Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Leukemia, Myeloid, Acute 6Multiple Myeloma 5Prostatic Neoplasms 4Neoplasm Metastasis 4Myelodysplastic Syndromes 4Lung Neoplasms 4Breast Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Mycosis Fungoides 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell 2Leukemia, Biphenotypic, Acute 2Glioma 2Colorectal Neoplasms 2Osteosarcoma 1Opioid-Related Disorders 1Neurofibrosarcoma 1Neurofibromatosis 1 1Neuroblastoma 1Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1

Interventions

lutetium Lu 177 dotatate 2gallium Ga 68 dotatate 2Magnetic Resonance Spectroscopy 2Ga(III)-DOTATOC 2lanreotide 1copper dotatate CU-64 1amino-acid, glucose, and electrolyte solution 1X-Rays 1Radiosurgery 1Octreotide 1Nivolumab 1Lutetium-177 1Lutetium 1Ipilimumab 1E-7386 1Disulfides 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Gastro-enteropancreatic neuroendocrine tumor × X-Rays × Clear all
NCT07150546 2026-03-02

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Emory University

Phase 1 Recruiting
15 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡